InflaRx N.V annual return on equity
2017
2018
2019
2020
2021
2022
2023
2024
2025
InflaRx N.V Return on Equity (ROE) Growth & History (IFRX)
InflaRx N.V's return on equity was −624.61% for fiscal 2025.
View full InflaRx N.V company overviewInflaRx N.V annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −624.61% | −3.07 pp |
| 2024 | 2024-12-31 | −621.54% | −38.62 pp |
| 2023 | 2023-12-31 | −582.92% | −10.81 pp |
| 2022 | 2022-12-31 | −572.11% | −459.32 pp |
| 2021 | 2021-12-31 | −112.79% | −76.05 pp |
| 2020 | 2020-12-31 | −36.74% | +4.46 pp |
| 2019 | 2019-12-31 | −41.20% | −19.18 pp |
| 2018 | 2018-12-31 | −22.02% | +29.70 pp |
| 2017 | 2017-12-31 | −51.71% | — |
InflaRx N.V quarterly return on equity
Q2.19
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −11.63% | +33.08 pp |
| Q1 2026 | 2026-03-31 | −25.39% | — |
| Q4 2025 | 2025-12-31 | −40.51% | — |
| Q3 2025 | 2025-09-30 | −23.94% | — |
| Q2 2025 | 2025-06-30 | −44.71% | −13.78 pp |
| Q2 2024 | 2024-06-30 | −30.93% | −18.49 pp |
| Q2 2023 | 2023-06-30 | −12.44% | −13.32 pp |
| Q2 2022 | 2022-06-30 | 0.88% | — |
| Q2 2019 | 2019-06-30 | −10.82% | — |
InflaRx N.V return on equity trends
Over the last five fiscal years, InflaRx N.V's return on equity decreased from −36.74% to −624.61%, a change of −587.87 percentage points. The latest reported quarter, Q2 2026, shows −11.63%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InflaRx N.V source filings ↗